e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ageing and disease duration may explain low sputum eosinophils in untreated moderate asthmatics
E. Bacci, M. Zingoni, S. Cianchetti, M. L. Bartoli, F. L. Dente, A. DiFranco, B. Vagaggini, A. DiPaco, P. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2003 - Asthma
Session:
Asthma
Session type:
Thematic Poster Session
Number:
3026
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bacci, M. Zingoni, S. Cianchetti, M. L. Bartoli, F. L. Dente, A. DiFranco, B. Vagaggini, A. DiPaco, P. Paggiaro (Pisa, Italy). Ageing and disease duration may explain low sputum eosinophils in untreated moderate asthmatics. Eur Respir J 2003; 22: Suppl. 45, 3026
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Eosinophilic inflammation in sputum of poorly controlled asthmatics
Source: Eur Respir J 2002; 20: 1370-1377
Year: 2002
Sputum eosinophil percentages during a moderate exacerbation of asthma and during a natural cold
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
Blood eosinophil in smokers and mild and moderate COPD patients
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017
Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002
Can blood eosinophils predict sputum eosinophils in stable COPD?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Reduced eosinophil apoptosis in induced sputum correlates with asthma severity
Source: Eur Respir J 2003; 22: 484-490
Year: 2003
High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Subjects in a population study with high levels of FENO have associated eosinophil airway inflammation in BAL
Source: Eur Respir J 2004; 24: Suppl. 48, 469s
Year: 2004
Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Sputum microbiota in moderate versus severe patients with COPD
Source: Eur Respir J 2014; 43: 1787-1790
Year: 2014
Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Mechanisms of noneosinophilic asthma
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma
Source: Eur Respir J 2014; 44: 895-904
Year: 2014
Sputum neutrophilic markers in asthma of varying severity and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 550s
Year: 2003
Sputum lymphocytes predict the severity of late asthmatic response in asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 227s
Year: 2004
A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics
Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept